The story of Viagra and its influence on the pharmaceutical sector presents a intricate question regarding its continued appeal as an investment. Initially a blockbuster success, generating billions , generic competition has considerably eroded financial returns. While established pharmaceutical firms maintain patents on escort related therapies an

The performance of companies tied to iconic drugs like Viagra presents a nuanced investment scenario . While the initial surge of copyright, fueled by Viagra's unprecedented popularity, generated substantial wealth , the expiry in key territories has introduced considerable uncertainty . Investors are now facing the consequences of generic competit